Clinical Trials Logo

Cardiovascular Disease clinical trials

View clinical trials related to Cardiovascular Disease.

Filter by:

NCT ID: NCT01698164 Recruiting - Breast Cancer Clinical Trials

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Start date: December 2008
Phase: Phase 4
Study type: Interventional

This study is to evaluate the benefit/risk of hormone replacement treatment among early menopausal women in China. This is a multi-centre, random, prospective study.

NCT ID: NCT01692574 Completed - Obesity Clinical Trials

Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)

TODI
Start date: August 2012
Phase: N/A
Study type: Interventional

To determine whether individuals who suffer from depression and obesity are able to lose weight and show improvements in mood and cardiovascular disease risk factors following 20 weeks of a combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss. Participants will be assigned to one of three treatments: 1) cognitive-behavior therapy for the treatment of depression combined with an alternative approach to weight loss, 2) a weight loss intervention combined with a depression support and education , or 3) cognitive-behavioral therapy for depression combined with a weight loss intervention.

NCT ID: NCT01692353 Completed - Clinical trials for Cardiovascular Disease

Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers

Start date: September 2008
Phase: N/A
Study type: Observational

This cross-sectional study was primarily a cardiovascular disease (CVD) study designed a) to compare selected CVD biomarker data between subjects who were long-term consumers of cigarettes or moist snuff and non-consumers of tobacco and b) to identify principal endpoints related to CVD risk that differed among the three tobacco-use cohorts. The following assessments provided the primary study endpoints for comparative analyses between the cohorts: 1. CVD-related physiological assessments: Flow-mediated dilation (FMD), carotid intima-media thickness (CIMT), ankle-brachial index (ABI), spirometry and expired carbon monoxide (ECO). 2. CVD-related biomarker assessments in blood and urine (biomarkers of tobacco effect). 3. Biomarkers of tobacco exposure in urine and blood.

NCT ID: NCT01690312 Completed - Clinical trials for Cardiovascular Disease

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Start date: September 2012
Phase: N/A
Study type: Interventional

The objective of this study is to determine the acute and chronic [4-week] effects of a high-DHA fish oil supplement on fasting and post-prandial (post-meal) biomarkers of cardiovascular disease risk, in adults on Statin therapy.

NCT ID: NCT01681030 Completed - Clinical trials for Cardiovascular Disease

The Fibrin Pad Cardiovascular Study

Start date: August 1, 2012
Phase: Phase 2
Study type: Interventional

This is a three-arm, randomized multicenter study evaluating the safety and effectiveness of EVARRESTâ„¢ Fibrin Sealant Patch in controlling mild to moderate vascular anastomosis suture line bleeding in cardiovascular surgery.

NCT ID: NCT01674231 Completed - Obesity Clinical Trials

The Effects Grapes on Health Indices

Start date: August 2012
Phase: N/A
Study type: Interventional

The investigators hope to learn about the effects of whole grapes, in the form of freeze-dried grape powder, on markers of health. Phytochemical rich food consumption is associated with protection against chronic diseases such as cardiovascular disease (CVD) demonstrating the ability to modify endothelial function and lipemia, but exact causal mechanisms are still not well understood. The investigators will examine metabolic and mechanistic effects of consumption of whole grape powder in chronic as well as acute settings in response to meal challenges by testing blood samples to determine if markers of health have improved. The central hypothesis of this project is that consumption of grapes in the form of a polyphenol-rich freeze-dried whole grape powder (WGP) will attenuate chronic and meal induced oxidative stress and inflammatory responses in obese individuals.

NCT ID: NCT01671696 Active, not recruiting - Clinical trials for Cardiovascular Disease

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

Start date: November 15, 2011
Phase:
Study type: Observational

The main hypothesis being tested is that magnetic resonance imaging and serologic biomarkers of apoptosis and extracellular matrix remodeling will precede echocardiographic indices of systolic and diastolic function among childhood cancer survivors treated with anthracyclines thus allowing evaluation of new therapies to prevent and manage heart failure in these patients.

NCT ID: NCT01671605 Completed - Clinical trials for Cardiovascular Disease

Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation

Start date: February 2013
Phase: N/A
Study type: Observational

There is currently little understanding of macrophage cholesterol homeostasis and foam cell formation across the spectrum of CKD. We hypothesize that an inverse relationship exist between the severity of CKD and processes underlying foam cell formation, and that the relationship becomes independent of serum lipoprotein levels as renal function declines. We propose to systematically examine scavenger receptors and cholesterol uptake as well as cholesterol transporters and efflux mechanisms in individuals with normal renal function, patients with moderate CKD and those with ESRD-HD. We further propose to determine if processed contributing to foam cell formation are related to the plasma lipid profile and if the relationship is modified by co-morbidities, such as diabetes, obesity, systemic inflammation which are common in this population and directly influence vascular integrity. These data will be critically important to understand when the abnormality starts and will provide crucial information.

NCT ID: NCT01667835 Recruiting - Clinical trials for Cardiovascular Disease

South Asian Women & Yoga Education Study

SAWYES
Start date: November 2012
Phase: Phase 1
Study type: Interventional

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

NCT ID: NCT01660828 Completed - Clinical trials for Cardiovascular Disease

Exercise Test and Cardiac Injury

Start date: September 2011
Phase: N/A
Study type: Interventional

Strenuous exercise in apparent healthy individuals increases plasma (high sensitive) troponin levels. The underlying mechanism is not yet elucidated, but could be explained by changes due to a mismatch in oxygen demand and supply that mimic those of ischemia and reperfusion injury. If the mechanism underlying the troponin release during exercise is similar to that of ischemia reperfusion injury (IRI), than it should be susceptible to remote ischemic preconditioning (RIPC) as RIPC is a well validated technique to reduce IRI. To test this hypothesis healthy volunteers underwent a strenuous exercise test with or without preceding RIPC.